A207 RIPK2 AND AMPK AS EMERGING THERAPEUTIC TARGETS FOR INFLAMMATORY BOWEL DISEASE

BACKGROUND: Persistent inflammation can trigger altered epigenetic, inflammation and bioenergetics states. Inflammatory bowel disease (IBD) is a heterogeneous disease with an abnormal inflammatory state and subsequent metabolic syndrome disorder. Current IBD therapeutics are directed to inhibit infl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Can Assoc Gastroenterol
Autors principals: Guo, Y, Dieleman, L A, Dooky, H, Joshi, H, Wine, E, Baksh, S
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Poster Presentation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043684/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz047.206
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars